HistoSonics, Inc.

HistoSonics’ acoustic energy platform has the potential to treat many clinical conditions non-invasively, reduce trauma, improve outcomes & lower cost of care.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Ann Arbor, MI, US
  • Currency USD
  • Founded 2009
  • Employees 12
  • Website histosonics.com

Company Summary

HistoSonics is a medical device startup commercializing a new type of focused ultrasound technology invented at the University of Michigan. Using a process known as histotripsy, HistoSonics’ image-guided acoustic-energy platform can ablate soft tissue non-invasively with high precision and without heat effects, offering the potential to improve the treatment of a wide range of urologic, neurologic, oncologic, and cardiovascular conditions.

Team

  • Christine Gibbons
    CEO, Board Director & Co-founder

    22+ years new company formation / investing / finance & operations, including Sensicore (acquired by GE), Venture Investors’ EIR, Ardesta, and Seaflower Ventures

  • Jim Bertolina
    VP R&D, CTO & Co-founder

    20+ years product innovation, technology and team development, including Xoran and Stryker (Surgical Navigation)

  • Michael Bunker
    VP Business Development

    15+ years in medical devices / venture capital at C.R. Bard, Medtronic, Arboretum and Early Stage Partners

  • Russell Jahnke
    Director Clinical, Quality & Regulatory

    17+ years product development and quality/compliance, including Xoran Technologies (mobile CT scanner)

  • Dejan Teofilovic
    Director Engineering

    17+ years product development, customer service, and technical support, including Xoran Technologies (mobile CT scanner)

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free